The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / From the Expert: Insight into the Intersection of Cancer & Autoimmunity

From the Expert: Insight into the Intersection of Cancer & Autoimmunity

March 4, 2016 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Science_Research_500x270When it comes to cancer and the autoimmune system, everything old is new again, says Antony Rosen, MD, director of the Division of Rheumatology at Johns Hopkins Hospital.

You Might Also Like
  • The Latest Data on Cancer Immunotherapy’s Interaction with Autoimmunity
  • Can Scleroderma Be Cured by Curing Cancer?
  • Link between Autoimmunity and Environmental Exposure Needs Further Research
Also By This Author
  • Patients with PsA, Cutaneous Psoriasis May Undergo Hip Replacement

His team’s work, linking cancer and scleroderma, revived the theory that people develop mutation-laden cells with the potential to transform into cancer. It also shows that through immunosurveillance the immune system edits cancer cells, says Dr. Rosen.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He recently discussed the topic in an interview with The Rheumatologist.

Antony Rosen, MD

Antony Rosen, MD

Question: What do you want rheumatologists to know about the intersection of cancer and autoimmunity?
Answer: The idea [is] that autoimmunity—and particularly the autoimmune rheumatic diseases—may be initiated in some individuals by changes in antigen structures that are found in cancer. [This] changes the way we think about the origins of autoimmunity … and understanding the way that the disease gets turned on (i.e., that there is a mutation in an antigen, which turns on a immunoresponse [and] acts to kill the cancer, but also acts to damage soft tissue). I think [it] is really a different concept.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: The idea that the immune system is editing cells on its own and could stop cancer before it starts is an exciting hypothesis, no?
A: There are great examples—case report kinds of examples, but they still are very tantalizing—that a patient can present with an autoimmune disease like scleroderma. You can find the cancer, remove the cancer, and both the cancer goes away and the scleroderma goes away. Now, that doesn’t happen universally, but there certainly are examples [that] are quite dramatic … Obviously, it’s a tantalizing thought and much more research needs to be put into that.

Q: Where does your research go from here?
A: Understanding complex human diseases is going to come from studying these diseases directly in humans. And the answers are likely going to require a broad multi-disciplinary expertise and the latest revolutionary tools of our day. I think that’s a very important concept. I think these diseases are going to be solved, and they are going to be solved in our professional lifetimes … It’s going to be a reflection of both the great clinical care and descriptions that have happened in the last hundred years, and the application of revolutionary tools of measurement and data analysis that we are currently blessed to have.

Richard Quinn is a freelance writer in New Jersey.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Scleroderma Tagged With: Cancer, Scleroderma, skin, skin inflammation

You Might Also Like:
  • The Latest Data on Cancer Immunotherapy’s Interaction with Autoimmunity
  • Can Scleroderma Be Cured by Curing Cancer?
  • Link between Autoimmunity and Environmental Exposure Needs Further Research
  • From the Expert: New Advances in Treatment of Systemic Scleroderma

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.